Proposed Data Collections Submitted for Public Comment and Recommendations, 75435-75436 [E8-29322]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices
You may submit all PRA
comments by e-mail or U.S. post mail.
To submit your comments by e-mail,
send them to PRA@fcc.gov. To submit
your comments by U.S. mail, mark them
to the attention of Cathy Williams,
Federal Communications Commission,
Room 1–C823, 445 12th Street, SW.,
Washington, DC 20554.
FOR FURTHER INFORMATION CONTACT: For
additional information about the
information collection(s), contact Cathy
Williams at (202) 418–2918 or send an
e-mail to PRA@fcc.gov.
SUPPLEMENTARY INFORMATION:
OMB Control Number: 3060–0161.
Title: Section 73.61, AM Directional
Antenna Field Strength Measurements.
Form Number: Not applicable.
Type of Review: Extension of a
currently approved collection.
Respondents: Business and other forprofit entities.
Number of Respondents and
Responses: 2,268.
Estimated Time per Response: 1–4
hours.
Frequency of Response:
Recordkeeping requirement.
Total Annual Burden: 36,020 hours.
Total Annual Costs: None.
Obligation to Respond: Required to
obtain or retain benefits. The statutory
authority for this information collection
is contained in Sections 154(i) and 303
of the Communications Act of 1934, as
amended.
Nature and Extent of Confidentiality:
There is no need for confidentiality with
this collection of information.
Privacy Impact Assessment(s): No
impact(s).
Needs and Uses: 47 CFR 73.61
requires that each AM station using
directional antennas to make field
strength measurement as often as
necessary to ensure proper directional
antenna system operation. Stations not
having approved sampling systems
make field strength measurements every
three months. Stations with approved
sampling systems must take field
strength measurements as often as
necessary. Also, all AM stations using
directional signals must take partial
proofs of performance as often as
necessary. The FCC staff used the data
in field inspections/investigations. AM
licensees with directional antennas use
the data to ensure that adequate
interference protection is maintained
between stations and to ensure proper
operation of antennas.
mstockstill on PROD1PC66 with NOTICES
ADDRESSES:
FEDERAL MARITIME COMMISSION
Meetings; Sunshine Act
AGENCY HOLDING THE MEETING:
Federal
Maritime Commission.
TIME AND DATE: December 17, 2008—
10 a.m.
PLACE: 800 North Capitol Street, NW.,
First Floor Hearing Room, Washington,
DC.
STATUS: A portion of the meeting will be
in Open Session and the remainder of
the meeting will be in Closed Session.
MATTERS TO BE CONSIDERED:
Open Session
(1) Budget Status Report.
Closed Session
(1) FMC Agreement No. 201199—Port
Fee Services Agreement.
(2) Staff Briefing Regarding Global
Economic Downturn and Potential
Impact on Stakeholders—Possible
Update.
(3) Internal Administrative Practices
and Personnel Matters.
CONTACT PERSON FOR MORE INFORMATION:
Tanga S. FitzGibbon, Alternate Federal
Register Liaison Officer, (202) 523–5725.
Tanga S. FitzGibbon,
Alternate Federal Register Liaison Officer.
[FR Doc. E8–29462 Filed 12–9–08; 4:15 pm]
BILLING CODE 6730–01–P
HARRY S. TRUMAN SCHOLARSHIP
FOUNDATION
Sunshine Act Meeting; Meeting of the
Trustees and Officers of the Harry S.
Truman Scholarship Foundation
December 16, 2008, 9:30 a.m.–11:30
p.m. U.S. Capitol, RHOB, Room 2212.
I. Call to order, Welcome, Approval of
the Minutes from September 18,
2007 meeting.
II. Approval of Selection of 2008
Truman Scholars.
III. Executive Secretary Report:
Development Fund.
IV. Report on 2008–2009 TrumanAlbright Fellows program.
V. Approval of a FY2009 Budget.
VI. Old Business.
VII. New Business.
VIII. Adjournment.
Federal Communications Commission.
Marlene H. Dortch,
Secretary.
[FR Doc. E8–29371 Filed 12–10–08; 8:45 am]
Dated: December 8, 2008.
Frederick G. Slabach,
Executive Secretary.
[FR Doc. E8–29421 Filed 12–9–08; 11:15 am]
BILLING CODE 6712–01–P
BILLING CODE 6820–AD–P
VerDate Aug<31>2005
17:27 Dec 10, 2008
Jkt 217001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
75435
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–09–0530]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of Information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments must be
received within 60 days of this notice.
Project Proposal
Energy Employees Occupational
Illness Compensation Program Act Dose
Reconstruction Interviews and Forms,
(OMB No. 0920–0530)—Extension—The
National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
On October 30, 2000, the Energy
Employees Occupational Illness
Compensation Program Act of 2000 (42
U.S.C. 7384–7385) was enacted. This
Act established a federal compensation
program for employees of the
Department of Energy (DOE) and certain
of its contractors, subcontractors and
vendors, who have suffered cancers and
other designated illnesses as a result of
exposures sustained in the production
and testing of nuclear weapons.
E:\FR\FM\11DEN1.SGM
11DEN1
75436
Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices
Executive Order 13179, issued on
December 7, 2000, delegated authorities
assigned to ‘‘the President’’ under the
Act to the Departments of Labor, Health
and Human Services, Energy and
Justice. The Department of Health and
Human Services (DHHS) was delegated
the responsibility of establishing
methods for estimating radiation doses
received by eligible claimants with
cancer applying for compensation.
NIOSH is applying the following
methods to estimate the radiation doses
of individuals applying for
compensation.
In performance of its dose
reconstruction responsibilities, under
the Act, NIOSH is providing voluntary
interview opportunities to claimants (or
their survivors) individually and
providing them with the opportunity to
assist NIOSH in documenting the work
history of the employee by
characterizing the actual work tasks
performed. In addition, NIOSH and the
claimant may identify incidents that
may have resulted in undocumented
radiation exposures, characterizing
radiological protection and monitoring
practices, and identify co-workers and
other witnesses as may be necessary to
confirm undocumented information. In
this process, NIOSH uses a computer
assisted telephone interview (CATI)
system, which allows interviews to be
conducted more efficiently and quickly
as opposed to a paper-based interview
instrument. Both interviews are
voluntary and failure to participate in
either or both interviews will not have
a negative effect on the claim, although
voluntary participation may assist the
claimant by adding important
information that may not be otherwise
available.
NIOSH uses the data collected in this
process to complete an individual dose
reconstruction that accounts, as fully as
possible, for the radiation dose incurred
by the employee in the line of duty for
DOE nuclear weapons production
programs. After dose reconstruction,
NIOSH also performs a brief, voluntary
final interview with the claimant to
explain the results and to allow the
claimant to confirm or question the
records NIOSH has compiled. This will
also be the final opportunity for the
claimant to supplement the dose
reconstruction record.
At the conclusion of the dose
reconstruction process, the claimant
submits a form to confirm that the
claimant has no further information to
provide to NIOSH about the claim at
this time. The form notifies the claimant
that signing the form allows NIOSH to
forward a dose reconstruction report to
Department of Labor (DOL) and to the
claimant, and closes the record on data
used for the dose reconstruction.
Signing this form does not indicate that
the claimant agrees with the outcome of
the dose reconstruction. The dose
reconstruction results will be supplied
to the claimant and to the DOL, the
agency that will utilize them as one part
of its determination of whether the
claimant is eligible for compensation
under the Act.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Number of responses per
respondent
Average burden (in hours)
Total response
burden hours
Initial interview .................................................................................................
Conclusion Form ..............................................................................................
4,200
8,400
1
1
1
5/60
4,200
700
Total ..........................................................................................................
........................
........................
........................
4,900
Dated: December 5, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–29322 Filed 12–10–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC66 with NOTICES
Centers for Disease Control and
Prevention/Health Resources and
Services Administration (CDC/HRSA)
Advisory Committee on HIV and STD
Prevention and Treatment
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the CDC/
HRSA Advisory Committee on HIV and
STD Prevention and Treatment,
Department of Health and Human
Services, has been renewed for a 2-year
period through November 25, 2010.
VerDate Aug<31>2005
17:27 Dec 10, 2008
Jkt 217001
FOR FURTHER INFORMATION CONTACT:
contact Kevin Fenton, M.D., Ph.D.,
Executive Secretary, CDC/HRSA
Advisory Committee on HIV and STD
Prevention and Treatment, Department
of Health and Human Services, 1600
Clifton Road, NE., Mailstop E07,
Atlanta, Georgia 30333, telephone (404)
639–8000 or fax (404) 639–8600.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: December 4, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–29325 Filed 12–10–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2007–D–0429] (formerly
Docket No. 2007D–0496)
Draft Guidance for Industry on
Questions and Answers Regarding the
Labeling of Nonprescription Human
Drug Products Marketed Without an
Approved Application as Required by
the Dietary Supplement and
Nonprescription Drug Consumer
Protection Act: Revision 1; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a revised draft guidance
entitled ‘‘Questions and Answers
Regarding the Labeling of
Nonprescription Human Drug Products
Marketed Without an Approved
Application as Required by the Dietary
Supplement and Nonprescription Drug
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 73, Number 239 (Thursday, December 11, 2008)]
[Notices]
[Pages 75435-75436]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29322]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-09-0530]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960 or
send comments to Maryam Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
Information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments must be received
within 60 days of this notice.
Project Proposal
Energy Employees Occupational Illness Compensation Program Act Dose
Reconstruction Interviews and Forms, (OMB No. 0920-0530)--Extension--
The National Institute for Occupational Safety and Health (NIOSH),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
On October 30, 2000, the Energy Employees Occupational Illness
Compensation Program Act of 2000 (42 U.S.C. 7384-7385) was enacted.
This Act established a federal compensation program for employees of
the Department of Energy (DOE) and certain of its contractors,
subcontractors and vendors, who have suffered cancers and other
designated illnesses as a result of exposures sustained in the
production and testing of nuclear weapons.
[[Page 75436]]
Executive Order 13179, issued on December 7, 2000, delegated
authorities assigned to ``the President'' under the Act to the
Departments of Labor, Health and Human Services, Energy and Justice.
The Department of Health and Human Services (DHHS) was delegated the
responsibility of establishing methods for estimating radiation doses
received by eligible claimants with cancer applying for compensation.
NIOSH is applying the following methods to estimate the radiation doses
of individuals applying for compensation.
In performance of its dose reconstruction responsibilities, under
the Act, NIOSH is providing voluntary interview opportunities to
claimants (or their survivors) individually and providing them with the
opportunity to assist NIOSH in documenting the work history of the
employee by characterizing the actual work tasks performed. In
addition, NIOSH and the claimant may identify incidents that may have
resulted in undocumented radiation exposures, characterizing
radiological protection and monitoring practices, and identify co-
workers and other witnesses as may be necessary to confirm undocumented
information. In this process, NIOSH uses a computer assisted telephone
interview (CATI) system, which allows interviews to be conducted more
efficiently and quickly as opposed to a paper-based interview
instrument. Both interviews are voluntary and failure to participate in
either or both interviews will not have a negative effect on the claim,
although voluntary participation may assist the claimant by adding
important information that may not be otherwise available.
NIOSH uses the data collected in this process to complete an
individual dose reconstruction that accounts, as fully as possible, for
the radiation dose incurred by the employee in the line of duty for DOE
nuclear weapons production programs. After dose reconstruction, NIOSH
also performs a brief, voluntary final interview with the claimant to
explain the results and to allow the claimant to confirm or question
the records NIOSH has compiled. This will also be the final opportunity
for the claimant to supplement the dose reconstruction record.
At the conclusion of the dose reconstruction process, the claimant
submits a form to confirm that the claimant has no further information
to provide to NIOSH about the claim at this time. The form notifies the
claimant that signing the form allows NIOSH to forward a dose
reconstruction report to Department of Labor (DOL) and to the claimant,
and closes the record on data used for the dose reconstruction. Signing
this form does not indicate that the claimant agrees with the outcome
of the dose reconstruction. The dose reconstruction results will be
supplied to the claimant and to the DOL, the agency that will utilize
them as one part of its determination of whether the claimant is
eligible for compensation under the Act.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Number of responses per Average burden Total response
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Initial interview............................... 4,200 1 1 4,200
Conclusion Form................................. 8,400 1 5/60 700
---------------------------------------------------------------
Total....................................... .............. .............. .............. 4,900
----------------------------------------------------------------------------------------------------------------
Dated: December 5, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. E8-29322 Filed 12-10-08; 8:45 am]
BILLING CODE 4163-18-P
